A Checklist Approach for Enhanced Outpatient Guideline-Directed Management in the Secondary Prevention of Atherosclerotic Cardiovascular Disease
References
- Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021 Feb 23;143(8):e254–e743. doi: 10.1161/CIR.0000000000000950
- Colantonio LD, Shannon ED, Orroth KK, et al. Ischemic Event Rates in Very-High-Risk Adults. J Am Coll Cardiol. 2019 Nov 19;74(20):2496–2507. doi: 10.1016/j.jacc.2019.09.025
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Jun 18;139(25):e1082–e1143. doi: 10.1161/CIR.0000000000000625
- Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004 May 15;116(10):682–92. doi: 10.1016/j.amjmed.2004.01.009
- Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM. Effects of the National Cholesterol Education Program’s Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr. 1999 Apr;69(4):632–46. doi: 10.1093/ajcn/69.4.632
- Estruch R, Ros E, Salas-Salvadó J, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018 Jun 21;378(25):
e34 . doi: 10.1056/NEJMoa1800389 - Maruthur NM, Wang NY, Appel LJ. Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial. Circulation. 2009 Apr 21;119(15):2026–31. doi: 10.1161/CIRCULATIONAHA.108.809491
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994 Nov 19;344(8934):1383–9. doi: 10.1016/S0140-6736(94)90566-5
- Pedersen TR, Faergeman O, Kastelein JP, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005 Nov 16;294(19):2437–45. doi: 10.1001/jama.294.19.2437
- Zelniker TA, Wiviott SD, Raz I, et al. Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus. Circulation. 2019 Apr 23;139(17):2022–2031. doi: 10.1161/CIRCULATIONAHA.118.038868
- Wormser D, Kaptoge S, Di Angelantonio E, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011 Mar 26;377(9771):1085–95. doi: 10.1016/S0140-6736(11)60105-0
- Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019 Jan 3;380(1):11–22. doi: 10.1056/NEJMoa1812792
- Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009 May 19;338:b1665. doi: 10.1136/bmj.b1665
- Ramsaran E, Preusse P, Sundaresan D, et al. Adherence to Blood Cholesterol Treatment Guidelines Among Physicians Managing Patients With Atherosclerotic Cardiovascular Disease. Am J Cardiol. 2019 Jul 15;124(2):169–175. doi: 10.1016/j.amjcard.2019.04.017
- Mahtta D, Ramsey DJ, Al Rifai M, et al. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Netw Open. 2020 Aug 3;3(8):
e2011051 . doi: 10.1001/jamanetworkopen.2020.11051 - Cannon CP, de Lemos JA, Rosenson RS, et al. Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US. JAMA Cardiol. 2021 Jun 16;
e211810 . doi: 10.1001/jamacardio.2021.1810 - Colantonio LD, Rosenson RS, Deng L, et al. Adherence to Statin Therapy Among US Adults Between 2007 and 2014. J Am Heart Assoc. 2019 Jan 8;8(1):
e010376 . doi: 10.1161/JAHA.118.010376 - De Backer G, Jankowski P, Kotseva K, et al. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis. 2019 Jun;285:135–146. doi: 10.1016/j.atherosclerosis.2019.03.014
- Walsh TS, Dodds S, McArdle F. Evaluation of simple criteria to predict successful weaning from mechanical ventilation in intensive care patients. Br J Anaesth. 2004 Jun;92(6):793–9. doi: 10.1093/bja/aeh139
- Hales BM, Pronovost PJ. The checklist–a tool for error management and performance improvement. J Crit Care. 2006 Sep;21(3):231–5. doi: 10.1016/j.jcrc.2006.06.002
- Reames BN, Krell RW, Campbell DA
Jr , Dimick JB. A checklist-based intervention to improve surgical outcomes in Michigan: evaluation of the Keystone Surgery program. JAMA Surg. 2015 Mar 1;150(3):208–15. doi: 10.1001/jamasurg.2014.2873 - Stroke.org [Internet]. Dallas, TX: American Heart Association; c2021. Secondary Stroke Prevention Checklist; 2021 [cited 2021 Sep 6]. Available from:
https://www.stroke.org/en/professionals/stroke-resource-library/post-stroke-care/stroke-prevention-checklist - Rehman H, Ahmed ST, Akeroyd J, et al. Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System). Am J Cardiol. 2019 Oct 15;124(8):1165–1170. doi: 10.1016/j.amjcard.2019.07.022
- Hakkennes S, Dodd K. Guideline implementation in allied health professions: a systematic review of the literature. Qual Saf Health Care. 2008 Aug;17(4):296–300. doi: 10.1136/qshc.2007.023804
- Barosi G. Strategies for dissemination and implementation of guidelines. Neurol Sci. 2006 Jun;27 Suppl 3:S231–4. doi: 10.1007/s10072-006-0624-9
- Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and Strategies in Guideline Implementation—A Scoping Review. Healthcare (Basel). 2016 Jun 29;4(3):36. doi: 10.3390/healthcare4030036
- Smith SC
Jr , Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011 Nov 29;58(23):2432–46. doi: 10.1016/j.jacc.2011.10.824 - Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010 Feb 2;121(4):586–613. doi: 10.1161/CIRCULATIONAHA.109.192703
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127–e248. doi: 10.1016/j.jacc.2017.11.006
- Virani SS, Morris PB, Agarwala A, et al. 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 Aug 31;78(9):960–993. doi: 10.1016/j.jacc.2021.06.011
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 Jun 25;73(24):e285–e350. doi: 10.1016/j.jacc.2018.11.003
- Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2016 Jul 5;68(1):92–125. doi: 10.1016/j.jacc.2016.03.519
- Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24;129(25 Suppl 2):S102–38. doi: 10.1161/01.cir.0000437739.71477.ee
- Das SR, Everett BM, Birtcher KK, et al. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 Sep 1;76(9):1117–1145. doi: 10.1016/j.jacc.2020.05.037
- Gundersen L. The effect of clinical practice guidelines on variations in care. Ann Intern Med. 2000 Aug 15;133(4):317–8. doi: 10.7326/0003-4819-133-4-200008150-00102
- Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009 Jan 29;360(5):491–9. doi: 10.1056/NEJMsa0810119
- Evans B. Best-practice protocols: VAP prevention. Nurs Manage. 2005 Dec 1;36(12):10, 12, 14 passim. doi: 10.1097/00006247-200512000-00004
- Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004 Mar;32(3):858–73. doi: 10.1097/01.CCM.0000117317.18092.E4
- Basoor A, Doshi NC, Cotant JF, et al. Decreased readmissions and improved quality of care with the use of an inexpensive checklist in heart failure. Congest Heart Fail. Jul-Aug 2013;19(4):200–6. doi: 10.1111/chf.12031
- Krishnamohan N, Maitra I, Shetty VD. The surgical ward round checklist: improving patient safety and clinical documentation. J Multidiscip Healthc. 2019 Sep 16;12:789–794. doi: 10.2147/JMDH.S178896
DOI: https://doi.org/10.14797/mdcvj.907 | Journal eISSN: 1947-6108
Language: English
Page range: 79 - 86
Submitted on: Aug 23, 2021
Accepted on: Sep 7, 2021
Published on: Sep 24, 2021
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2021 Mohamad B. Taha, Eleonora Avenatti, Daniel S. Li, Tirhas Ohonba, Miguel Cainzos-Achirica, Kershaw V. Patel, Khurram Nasir, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.